Stock Events

Stock Events

Lonza Group 

$745.00
211
+$15.40+2.11%Monday 19:54

Statistics

Day High
745
Day Low
745
52W High
755.96
52W Low
565.14
Volume
12
Avg. Volume
206
Mkt Cap
52.03B
P/E Ratio
45.46
Dividend Yield
0.43%
Dividend
3.18

Upcoming

Dividends

0.43%Dividend Yield
May 2026
$3.18
May 2026
$3.18
May 2025
$2.39
May 2025
$2.39
May 2024
$2.22
10Y Growth
N/A
5Y Growth
16.87%
3Y Growth
17.53%
1Y Growth
32.69%

Earnings

Jan 27Expected
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
Next
0
3.99
7.99
11.98
Expected EPS
11.278474
Actual EPS
N/A

Financials

-4.2%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
8.24BRevenue
-346.04MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LZAGF. It's not an investment recommendation.
Nestle SA
55
NESN.SW
Novartis
45
NOVN.SW
Microsoft
42
MSFT
Swiss Re
36
SREN.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific offers similar biotechnology and pharmaceutical services, including contract manufacturing and development services, competing directly with Lonza's core business.
Danaher
DHR
Mkt Cap150.48B
Danaher Corporation, through its Life Sciences segment, competes in the bioprocessing space, offering products and services that overlap with Lonza's offerings in pharmaceutical development and manufacturing.
Charles River Laboratories International
CRL
Mkt Cap13.85B
Charles River Laboratories provides a range of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, competing with Lonza in contract development and manufacturing organization (CDMO) services.
IQVIA
IQV
Mkt Cap42.5B
IQVIA offers extensive clinical research services, including biopharmaceutical development, which competes with Lonza's services in drug development and manufacturing.
West Pharmaceutical Services
WST
Mkt Cap25.69B
West Pharmaceutical Services specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products, competing with Lonza in the pharmaceutical and biotech supply chain.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories offers products and services in life science research and clinical diagnostics, competing with Lonza in the provision of specialized instruments and reagents for the pharmaceutical industry.

About

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. It offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to dosage forms for the pharma and consumer health, and nutrition industries, as well as develops cell and gene therapies. The company also provides drinking water sanitizers, nutraceuticals, antidandruff agents, and other personal care ingredients; and agricultural products and advanced coatings and composites, as well as microbial control solutions that combat dangerous viruses, bacteria, and other pathogens. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
Show More
CEO
Wolfgang Wienand
Employees
16866
Country
Switzerland
ISIN
CH0013841017
WKN
000928619

Listings

MI
IT
1LONN.MI
XETRA
DE
LO3.XETRA
MX
MX
LONNN.MX
MU
DE
LO3.MU

0 Comments

Share your thoughts

FAQs

What is Lonza Group stock price today?▼
The current price of LZAGF is $745.00 USD — it has increased by +2.11% in the past 24 hours. Watch Lonza Group stock price performance more closely on the chart.
What is Lonza Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Lonza Group stocks are traded under the ticker LZAGF.
Is Lonza Group stock price growing?▼
LZAGF stock has risen by +9.85% compared to the previous week, the month change is a +11.66% rise, over the last year Lonza Group has showed a +3.93% increase.
What is Lonza Group market cap?▼
Today Lonza Group has the market capitalization of 52.03B
When is the next Lonza Group earnings date?▼
Lonza Group is going to release the next earnings report on January 27, 2027.
What were Lonza Group earnings last quarter?▼
LZAGF earnings for the last quarter are 10.09 USD per share, whereas the estimation was 10.76 USD resulting in a -6.19% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lonza Group revenue for the last year?▼
Lonza Group revenue for the last year amounts to 8.24B USD.
What is Lonza Group net income for the last year?▼
LZAGF net income for the last year is -346.04M USD.
Does Lonza Group pay dividends?▼
Yes, LZAGF dividends are paid annual. The last dividend per share was 3.18 . As of today, Dividend Yield (FWD)% is 0.43%.
How many employees does Lonza Group have?▼
As of October 20, 2026, the company has 16,866 employees.
In which sector is Lonza Group located?▼
Lonza Group operates in the Health & Wellness sector.
When did Lonza Group complete a stock split?▼
Lonza Group has not had any recent stock splits.
Where is Lonza Group headquartered?▼
Lonza Group is headquartered in Basel, Switzerland.